Top US experts on Timesnownews.com - From geopolitics to AI to lifestyle, get the views from the best in the world.

Skepticism about the government’s pandemic response is one thing. Writing off mRNA vaccine technology is another.

The FDA approved Moderna's mFlusiva in August, and it's now available to adults 50 and older.

Now is around the time when flu season usually starts to pick up — except this year, cases have been rising since late summer ...

For some older adults, the flu vaccine could look a little different this year. In August, the US Food and Drug Administration approved the nation’s first mRNA-based flu vaccine for use in people 50 ...

The first mRNA flu shot is now available, but not everyone is eligible. Moderna’s mFlusiva is the first flu vaccine in the United States to use messenger RNA technology, the same platform used in ...

The FDA has approved mFlusiva, the first mRNA flu vaccine, for adults ages 50 to 64, but the CDC has not added it to its recommended list amid legal uncertainties and disruptions to the federal ...

The flu might be a relatively common illness, but it’s nothing to mess around with. The Centers for Disease Control and Prevention (CDC) estimates that in a typical year, the flu kills tens of ...

One of the beneficial characteristics of the response to the COVID -19 pandemic were pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech, and others) not to ...